Smartwatch-Based AI Model for OSA Prediction (SWOSA)

Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Jan 19, 2025

Keywords

ClinConnect Summary

The SWOSA trial is studying a new way to diagnose obstructive sleep apnea (OSA) using a smartwatch that collects health information while you sleep. OSA is a common condition where your breathing temporarily stops during sleep, often causing snoring and excessive daytime sleepiness. The current standard test for OSA can be expensive and complicated, so this study aims to create an artificial intelligence (AI) model that uses data from smartwatches—like blood oxygen levels and heart rate—to help identify OSA more easily and affordably.

To participate in the trial, you should be between 22 and 85 years old and have visited Seoul National University Hospital with symptoms suggesting you may have sleep apnea. However, if you already have a diagnosis of sleep apnea and are receiving treatment, or if you have certain medical conditions, you may not be eligible. If you decide to join, you can expect to wear a smartwatch while you sleep, which will help researchers gather important data to improve OSA diagnosis. This trial is not yet recruiting participants, but it could lead to better and more accessible ways to detect and treat sleep apnea in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Men and women aged 22 to 85 years who visited Seoul National University Hospital with suspected sleep apnea due to symptoms such as snoring, apnea, or excessive daytime sleepiness.
• Exclusion Criteria:
• • Patients previously diagnosed with sleep apnea who are currently undergoing treatment (e.g., positive airway pressure \[PAP\] therapy, mechanical ventilation, oral appliances, or surgery).
• • Patients with neuromuscular diseases or a history of chronic opioid medication use.
• • Patients with severe insomnia that is not controlled by medication.
• • Patients receiving supplemental oxygen therapy due to underlying conditions such as heart failure, chronic obstructive pulmonary disease, interstitial lung disease, hypoventilation syndrome, or stroke, or whose baseline oxygen saturation is less than 90%.
• • Patients with implanted cardiac pacemakers, defibrillators, or other electronic devices.
• • Patients inexperienced in using smartphones, apps, or smartwatches.
• • Pregnant women.
• • Patients unable or unwilling to provide written informed consent.